Spinal Cord Atrophy Is a Preclinical Marker of Progressive <scp>MS</scp>

Burcu Zeydan; Maria A. Rocca; Orhun H. Kantarci; Massimo Filippi

doi:10.1002/ana.26341

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2019

Spinal Cord Atrophy in Neuromyelitis Optica Is Associated to Spinal Cord Lesions and Clinical Disability (P1.2-071)

Laura Cacciaguerra, Paola Valsasina, Šarlota Mesaroš, Jelena Drulović, Alessandro Meani, Massimo Filippi, Maria A. Rocca

Article2018

Progressive neurodegeneration following spinal cord injury

Gabriel Ziegler, Patrick Grabher, Alan J. Thompson, Daniel R. Altmann, Markus Hupp, John Ashburner, Karl Friston, Nikolaus Weiskopf, Armin Curt, Patrick Freund

Article2018

Quantification of spinal cord atrophy in MS: which software, which vertebral level, spinal cord or brain MRI? A multi-centric, longitudinal comparison of three different volumetric approaches.

Carsten Lukas, Ferrán Prados, Paola Valsasina, Katrin Parmar, Iman Brouwer, Barbara Bellenberg, A. Rovira, Declan Chard, Ludwig Kappos, Maria A. Rocca, Massimo Filippi, Olga Ciccarelli, Frederik Barkhof, Hugo Vrenken

Article2020

Spinal Cord Atrophy in Neuromyelitis Optica Spectrum Disorders Is Spatially Related to Cord Lesions and Disability

Laura Cacciaguerra, Paola Valsasina, Šarlota Mesaroš, Vittorio Martinelli, Jelena Drulović, Massimo Filippi, Maria A. Rocca

Article2021

Improved Assessment of Longitudinal Spinal Cord Atrophy in Multiple Sclerosis Using a <scp>Registration‐Based</scp> Approach: Relevance for Clinical Studies

Paola Valsasina, Mark A. Horsfield, Alessandro Meani, Claudio Gobbi, Antonio Gallo, Maria A. Rocca, Massimo Filippi